Trials / Completed
CompletedNCT00883870
Mesenchymal Stem Cells in Critical Limb Ischemia
A Randomized, Double Blind, Multicentric, Placebo Controlled, Single Dose, Phase - i/ii Study Assessing the Safety and Efficacy of Intramuscular ex Vivo Cultured Adult Allogenic Mesenchymal Stem Cells in Patients With Critical Limb Ischemia (Cli)
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Stempeutics Research Pvt Ltd · Industry
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
This clinical trial aims to study the safety and efficacy of adult mesenchymal stem cells in critical limb ischemia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | mesenchymal stem cells | Intramuscular injection |
| DRUG | Plasmalyte A | Intramuscular injection |
Timeline
- Start date
- 2009-04-01
- Primary completion
- 2010-02-01
- Completion
- 2012-08-01
- First posted
- 2009-04-20
- Last updated
- 2013-03-05
Locations
4 sites across 1 country: India
Source: ClinicalTrials.gov record NCT00883870. Inclusion in this directory is not an endorsement.